Key result
Midlife hypertension is consistently linked to later-life cognitive decline and dementia, unlike late-life hypertension.
Why the study?
While midlife hypertension consistently links to cognitive decline, findings regarding late-life hypertension and dementia risk remain inconsistent.
Does arterial hypertension increase the risk of cognitive decline and dementia?
Does arterial hypertension increase the risk of cognitive decline and dementia?
Midlife hypertension is a consistent risk factor for cognitive decline and dementia, highlighting the potential importance of early blood pressure management for cognitive preservation.
Midlife BP control may aid cognitive preservation; confirms consistent midlife risk while leaving late-life effects unresolved.
The global increase in dementia cases, driven by improved life expectancy and reduced elderly mortality rates, presents a significant public health challenge. Dementia, characterized by a gradual and irreversible decline in cognitive abilities, affects individuals aged 65 and older, disrupting lives and straining healthcare systems. Hypertension significantly influences dementia development. Research consistently links midlife hypertension to cognitive decline, mild cognitive impairment (MCI), and dementia, but findings in older adults vary. While some studies suggest that late-life hypertension accelerates cognitive decline and dementia risk, others propose a protective effect. The impact of hypertension on cognition varies across age groups, spanning from childhood to late life. High blood pressure during midlife and earlier life stages consistently predicts poorer cognitive outcomes. Executive function, attention, and motor speed are the cognitive domains most affected by hypertension, particularly in subcortical diseases. Memory impairments in hypertension-related dementias are complex, often overlapping with other causes. Understanding the inconsistent findings in older adults regarding hypertension, cognitive decline, and dementia risk requires comprehensive exploration of methodological and biological factors. Addressing hypertension and its management may hold the key to reducing the risk of cognitive decline and dementia, especially in midlife and earlier life stages.
No takes yet. Share an insight, caveat, or question.
Salazar et al. (2024) conducted a review in Cognitive Impairment and Dementia. Arterial hypertension vs. Normotension was evaluated. Midlife hypertension consistently increases the risk of cognitive decline, mild cognitive impairment, and dementia in later life, whereas the impact of late-life hypertension remains inconsistent.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: